Reply to: "Male-to-female ratios in the risk of hepatocellular carcinoma: A nationwide study of Danish patients with viral or non-viral cirrhosis": Advocating for scalable etiology-agnostic HCC risk models for personalized HCC surveillance.
사설/논평
0/5 보강
APA
Nahon P, Ganne-Carrié N (2025). Reply to: "Male-to-female ratios in the risk of hepatocellular carcinoma: A nationwide study of Danish patients with viral or non-viral cirrhosis": Advocating for scalable etiology-agnostic HCC risk models for personalized HCC surveillance.. Journal of hepatology, 83(6), e297-e298. https://doi.org/10.1016/j.jhep.2025.09.005
MLA
Nahon P, et al.. "Reply to: "Male-to-female ratios in the risk of hepatocellular carcinoma: A nationwide study of Danish patients with viral or non-viral cirrhosis": Advocating for scalable etiology-agnostic HCC risk models for personalized HCC surveillance.." Journal of hepatology, vol. 83, no. 6, 2025, pp. e297-e298.
PMID
40975406 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial).
- Comparative evaluation of regression and machine-learning models for hepatocellular carcinoma risk stratification across diverse aetiologies.
- Establishing five-year overall survival as a new standard for trials in advanced HCC.
- Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- Heat Shock Protein 47 as a Novel Predictive and Diagnostic Biomarker for Thrombosis in Hepatocellular Carcinoma.
- Characterization of liver disease in a cohort of individuals with Niemann-Pick Disease, Type C1.
- Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison.
- Global economic differences in modern glioblastoma care - a systematic review.
- Cost-Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan.